Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

University of Toronto

$90,000.00

HIV-1 glycoprotein gp41's roles in both immune misdirection and suppression

EF 2020-21

Résumé
Viruses need access to the inside of a host's cells in order to proliferate and launch an effective infection. They have therefore developed protein molecules to fuse with the outside of human cells and subsequently transfer themselves (or at least the portions required for duplication) within. These fusion proteins are called viral glycoproteins (GPs). However, viruses produce few types of proteins, meaning that many viral proteins must pull double or triple duty and take on additional roles. This is true of a GP from HIV (gp41), which - besides its role in viral entry -also interacts with and negatively impacts the host's immune system. This is done in two ways: 1) Immunodominance - gp41 contains two unique segments that draw the production of host-made antibodies to them, misdirecting these protective molecules away from areas that prevent infection; and 2) Immunosuppression - gp41 contains a segment that interacts directly with immune cells and suppresses their activity. Our goal is to understand how the different segments of gp41 achieve these two processes, providing a comprehensive overview of how viruses like HIV avoid the immune system. We will determine the shape and chemical properties of the gp41 immunodominant regions to elucidate why these segments are bound preferentially by human antibodies. Preliminary results have shown that the two segments use different mechanisms, one taking up many different shapes to be easily recognized by different antibodies, with the other binding with a single shape but with exceptional strength. We will also determine how the immunosuppressive region is able to interact with human immune cells. Initial data suggests that this region of gp41 binds to only certain types of immune cells, implying a preference for molecular components on these cells' surfaces. Our studies will impact the future production of HIV vaccines and antivirals, bringing further weapons to bear on a virus infamous for its debilitating infections.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
441154
Name
Vance Tyler D
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
HIV-1 glycoprotein gp41's roles in both immune misdirection and suppression
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$90,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Antigen-Antibody Interaction; Biophysical Assays; Discovery Of Immune Evasion Mechanisms; Hiv Glycoproteins; Immune Modulations (Suppression V. Dominance); Molecular Dynamics Simulations; Nuclear Magnetic Resonance; Vaccine Design; Viral Fusion; X-Ray Crystallography
Abstract
Viruses need access to the inside of a host's cells in order to proliferate and launch an effective infection. They have therefore developed protein molecules to fuse with the outside of human cells and subsequently transfer themselves (or at least the portions required for duplication) within. These fusion proteins are called viral glycoproteins (GPs). However, viruses produce few types of proteins, meaning that many viral proteins must pull double or triple duty and take on additional roles. This is true of a GP from HIV (gp41), which - besides its role in viral entry -also interacts with and negatively impacts the host's immune system. This is done in two ways: 1) Immunodominance - gp41 contains two unique segments that draw the production of host-made antibodies to them, misdirecting these protective molecules away from areas that prevent infection; and 2) Immunosuppression - gp41 contains a segment that interacts directly with immune cells and suppresses their activity. Our goal is to understand how the different segments of gp41 achieve these two processes, providing a comprehensive overview of how viruses like HIV avoid the immune system. We will determine the shape and chemical properties of the gp41 immunodominant regions to elucidate why these segments are bound preferentially by human antibodies. Preliminary results have shown that the two segments use different mechanisms, one taking up many different shapes to be easily recognized by different antibodies, with the other binding with a single shape but with exceptional strength. We will also determine how the immunosuppressive region is able to interact with human immune cells. Initial data suggests that this region of gp41 binds to only certain types of immune cells, implying a preference for molecular components on these cells' surfaces. Our studies will impact the future production of HIV vaccines and antivirals, bringing further weapons to bear on a virus infamous for its debilitating infections.
Competitiondate
202012
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Vance, Tyler D
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $90,000~ $0~